Ani Pharmaceuticals (ANIP) Total Debt Growth (1y) (2012 - 2026)
Powered by 
Analysis
Ani Pharmaceuticals (ANIP) Total Debt Growth (1y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -3.69% |
| 2 | Viatris | 19.20 Bn | 18.31 Bn | 1.46 Bn | -7.75% |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.73 Bn | 396.53 Mn | 60.10% |
| 4 | Amneal Pharmaceuticals | 5.49 Bn | 5.36 Bn | 334.51 Mn | 8.22% |
| 5 | Bausch Health Companies | 2.31 Bn | 475.75 Mn | 2.10 Bn | -4.47% |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | - |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | -4.20% |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 711.29 Mn | 93.47 Mn | 0.56% |
| 9 | Fennec Pharmaceuticals | 396.40 Mn | 355.15 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -4.20% |
| Mar 31, 2026 | -3.54% |
| Dec 31, 2025 | -2.88% |
| Sep 30, 2025 | -2.23% |
| Jun 30, 2025 | 10.33% |
| Mar 31, 2025 | 10.87% |
| Dec 31, 2024 | 7.13% |
| Sep 30, 2024 | 3.59% |
| Jun 30, 2024 | -8.07% |
| Mar 31, 2024 | -7.38% |
| Dec 31, 2023 | 3.69% |
| Sep 30, 2023 | 7.76% |
| Jun 30, 2023 | 8.13% |
| Mar 31, 2023 | 7.33% |
| Dec 31, 2022 | -0.30% |
| Sep 30, 2022 | 41.95% |
| Jun 30, 2022 | 40.17% |
| Mar 31, 2022 | 56.55% |
| Dec 31, 2021 | 54.76% |
| Sep 30, 2021 | 7.47% |